---
title: "ATWOOD BRIAN G — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0e37ddca-e87b-5eaf-b87a-aa4dc0a376eb
json: https://whiteintel.dev/api/public/dossier/0e37ddca-e87b-5eaf-b87a-aa4dc0a376eb
identifier: sec:0001266567
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# ATWOOD BRIAN G

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001266567`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/0e37ddca-e87b-5eaf-b87a-aa4dc0a376eb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0e37ddca-e87b-5eaf-b87a-aa4dc0a376eb  

## Ownership & control

### Holdings / subsidiaries

- **CERO THERAPEUTICS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/2697394b-725e-5a82-b8b3-2ae53dbf37b3
- **CERO THERAPEUTICS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/2697394b-725e-5a82-b8b3-2ae53dbf37b3
- **CERO THERAPEUTICS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/2697394b-725e-5a82-b8b3-2ae53dbf37b3
- **ALEXZA PHARMACEUTICALS INC.** (tenpercentowner) — https://whiteintel.dev/entity/c572037c-1283-52e7-9b39-62e059e79c11
- **ALEXZA PHARMACEUTICALS INC.** (other) — https://whiteintel.dev/entity/c572037c-1283-52e7-9b39-62e059e79c11
- **CERO THERAPEUTICS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/2697394b-725e-5a82-b8b3-2ae53dbf37b3
- **LAUNCH ONE ACQUISITION CORP.** (director) — https://whiteintel.dev/entity/6bdb8e17-e83b-5d48-8222-4f7fef0cbc5e
- **CERO THERAPEUTICS HOLDINGS, INC.** (officer) — https://whiteintel.dev/entity/2697394b-725e-5a82-b8b3-2ae53dbf37b3
- **ATRECA, INC.** (director) — https://whiteintel.dev/entity/aeb51467-2b41-587b-87af-73bd0741cfbf
- **CLOVIS ONCOLOGY, INC.** (director) — https://whiteintel.dev/entity/ccaa9690-bbbe-58b5-88c3-0bf8d7895820
- **EFFECTOR THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/46e80e50-89ed-556b-bb94-8235a6d07499
- **PHASERX INC** (director) — https://whiteintel.dev/entity/c4aacf31-87ad-5ce3-96ef-2b2c3fef4711
- **PHASERX INC** (tenpercentowner) — https://whiteintel.dev/entity/c4aacf31-87ad-5ce3-96ef-2b2c3fef4711
- **VERACYTE, INC.** (tenpercentowner) — https://whiteintel.dev/entity/db676850-6768-531c-a16a-e5eba6c51abe
- **CAPFORCE INC.** (director) — https://whiteintel.dev/entity/8cbf8f7a-d956-5276-86c1-8e4b7469b5cb
- **CAPFORCE INC.** (tenpercentowner) — https://whiteintel.dev/entity/8cbf8f7a-d956-5276-86c1-8e4b7469b5cb
- **FLEXION THERAPEUTICS INC** (tenpercentowner) — https://whiteintel.dev/entity/8a691bad-e50b-5a45-9758-49ded5f0b4a3
- **VERACYTE, INC.** (director) — https://whiteintel.dev/entity/db676850-6768-531c-a16a-e5eba6c51abe
- **GLAUKOS Corp** (other) — https://whiteintel.dev/entity/87a837ae-17b5-5acc-9137-4cbf184f8e38
- **IMMUNE DESIGN CORP.** (director) — https://whiteintel.dev/entity/90dcaf96-fc16-5591-8d81-164c9a7e0cff
- **FIVE PRIME THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/9aff28e2-4669-58d2-ac70-a8796893d4c8
- **GLAUKOS Corp** (tenpercentowner) — https://whiteintel.dev/entity/87a837ae-17b5-5acc-9137-4cbf184f8e38
- **Inogen Inc** (tenpercentowner) — https://whiteintel.dev/entity/09aedda7-2e6b-52d3-afb0-33f02c5e272f
- **Vivani Medical, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/45de99b4-c9d6-5964-adb1-700b53cc6621
- **IMMUNE DESIGN CORP.** (tenpercentowner) — https://whiteintel.dev/entity/90dcaf96-fc16-5591-8d81-164c9a7e0cff
- **FLEXION THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/8a691bad-e50b-5a45-9758-49ded5f0b4a3
- **CADENCE PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/ff55dd18-b12e-51cb-b677-6dcc0685d128
- **RX3 PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/c004085a-f284-5a30-8fa6-7a56558e8fa1
- **CLOVIS ONCOLOGY, INC.** (tenpercentowner) — https://whiteintel.dev/entity/ccaa9690-bbbe-58b5-88c3-0bf8d7895820
- **RX3 PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/c004085a-f284-5a30-8fa6-7a56558e8fa1
- **HELICOS BIOSCIENCES CORP** (director) — https://whiteintel.dev/entity/9d7f63d8-f365-577a-91b0-da7b4dae670f
- **HELICOS BIOSCIENCES CORP** (tenpercentowner) — https://whiteintel.dev/entity/9d7f63d8-f365-577a-91b0-da7b4dae670f
- **PHARMION CORP** (director) — https://whiteintel.dev/entity/4890c9d3-a5c8-5b0b-9607-088939b34168
- **INSULET CORP** (tenpercentowner) — https://whiteintel.dev/entity/3d1f71c0-5f31-5390-8a99-e7760bfd5e96
- **INSULET CORP** (other) — https://whiteintel.dev/entity/3d1f71c0-5f31-5390-8a99-e7760bfd5e96
- **NOVACEA INC** (tenpercentowner) — https://whiteintel.dev/entity/ae254050-c680-5a04-8774-2e41a4af64eb

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ATWOOD BRIAN G**. Human view: https://whiteintel.dev/entity/0e37ddca-e87b-5eaf-b87a-aa4dc0a376eb · Structured JSON: https://whiteintel.dev/api/public/dossier/0e37ddca-e87b-5eaf-b87a-aa4dc0a376eb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._